Skip to main content
An official website of the United States government

Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Please check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
NIH Research Project Grant PA-25-301 (Parent R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 01/07/2028 Asad Umar, D.V.M., Ph.D.
NIH Exploratory/Developmental Research Project Grant PA-25-304 (Parent R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/08/2028 Marjorie Perloff, M.D.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes PAR-25-095 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 09/07/2026 Wendy Wang, Ph.D., M.Sc.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-25-074 (UH2/UH3 Clinical Trial Not Allowed) UH2, UH3 Clinical Trial Not Allowed 10/14/2026 Sudhir Srivastava, Ph.D., M.P.H.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-25-069 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/07/2027 Edward Sauter, M.D., Ph.D.
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research PAR-24-153 (K12 Clinical Trial Optional) K12 Clinical Trial Optional 02/19/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Enhancing Mechanistic Research on Precision Probiotic Therapies PAR-25-211 (R61/R33 Clinical Trial Optional) R61, R33 Clinical Trial Optional 06/02/2027 Gabriela Riscuta, M.D., CNS
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-25-043 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/07/2028 Edward Sauter, M.D., Ph.D.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-25-145 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/07/2028 Rachel Altshuler, Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-287 (K99/R00 - Independent Clinical Trial Required) R00, K99 Clinical Trial Required 10/15/2026 Asad Umar, D.V.M., Ph.D.